Table 2.
Participants’ choices of secondary findings.
| Category 1: Medically actionable diseases |
Category 2: Common disease SNPs |
Category 3: Rare Mendelian disorders |
Category 4: Early-onset neurological conditions |
Category 5: Carrier status |
|
|---|---|---|---|---|---|
| Yes | 30 (96.8%) | 24 (77.4%) | 21 (67.7%) | 20 (64.5%) | 23 (74.2%) |
| No | 1 (3.2%) | 6 (19.4%) | 6 (19.4%) | 7 (22.6%) | 5 (16.1%) |
| Unsure | 0 (0%) | 1 (3.2%) | 4 (12.9%) | 4 (12.9%) | 3 (9.7%) |